Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 6 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

4(80.0%)

Phase 2

1(20.0%)

5Total

N/A(4)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT03206801Phase 2Completed

Urine CXCL10 Monitoring Trial in Kidney Transplant

Role: collaborator

NCT06370832Not ApplicableRecruiting

Inspiratory Muscle Training in Lung Transplant Candidates

Role: collaborator

NCT04965142Not ApplicableCompleted

Feasibility of a Home Exercise Program to Manage Post-transplant Metabolic Syndrome

Role: collaborator

NCT05033327Not ApplicableCompleted

Feasibility of an App-based Nutrition & Exercise Program in Cirrhosis

Role: collaborator

NCT04661787Unknown

Donation Advisor Clinical Decision Support Tool Study

Role: collaborator

NCT02784756Not ApplicableCompleted

Cell-Mediated Immunity Based Primary Prophylaxis for CMV Infection in Organ Transplant Recipients

Role: collaborator

NCT03114436Completed

National Observational Study of Clinical Practices in Deceased Organ Donation

Role: collaborator

NCT02902783Completed

DONATE-Pilot Study on ICU Management of Deceased Organ Donors

Role: collaborator

NCT03128918Unknown

Non-invasive Diagnosis of Non-alcoholic Steatohepatitis in Liver Transplant Recipients

Role: collaborator

All 9 trials loaded